January 15, 2018 / 7:24 AM / Updated 30 minutes ago BRIEF-Shire Says Granted EU marketing Authorization For ADYNOVI For Adults And Adolescents With Hemophilia A Reuters Staff 1 Min Read 
Jan 15 (Reuters) - Shire Plc: 
* SHIRE GRANTED EU MARKETING AUTHORIZATION FOR ADYNOVI [ANTIHEMOPHILIC FACTOR (RECOMBINANT), PEGYLATED] FOR ADULTS AND ADOLESCENTS WITH HEMOPHILIA A​ 
* ‍SHIRE IS NOW AUTHORIZED TO MARKET ADYNOVI IN 28 MEMBER STATES OF EUROPEAN UNION (EU), AS WELL AS IN ICELAND, LIECHTENSTEIN AND NORWAY​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)